Despite the drop in top-line revenue, the company maintained steady margins through a more selective, demand-led sourcing model. By purchasing higher-quality tobacco at lower costs, Pyxus navigated a market defined by ample supply and reduced pricing. Operating income landed at $15.7 million, compared to $21 million in the same quarter last year, while net loss narrowed to $7.3 million from $15.8 million, bolstered by a $5.7 million income tax benefit.
Management confirmed its full-year guidance, projecting net sales between $2.3 billion and $2.5 billion. The company also successfully reduced its net debt by $130.9 million, bringing the total to $1.11 billion as of June 30, 2026. President and CEO Pieter Sikkel noted that these results align with the company's internal purchasing plans and strategic efforts to strengthen the balance sheet across varying market conditions.

Comments (0)
No comments yet. Be the first!